ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
2,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
2,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
2,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
3,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
4,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
4,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
4,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
5,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
6,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
7,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
7,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
7,3,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
7,4,Diet noncompliance,Dietary and nutritional issues,Lifestyle issues,SocCi,N
7,5,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
8,1,Eye operation,Eye therapeutic procedures NEC,Eye therapeutic procedures,Surg,N
8,2,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
9,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
9,2,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
10,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
10,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
10,3,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
11,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
11,2,Lupus vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
11,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11,4,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
12,1,Eye haemorrhage,Ocular bleeding and vascular disorders NEC,Ocular haemorrhages and vascular disorders NEC,Eye,N
13,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
13,2,Therapy cessation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
